Showing results (21-30 of 33) with videos related to
Sort By:
Pageof 4
Archives of Dermatological Research|April 19, 2003
Downregulation of tapasin expression in progressive human malignant melanomaJ Dissemond, T Kothen, J Mörs, et al.Cell Death & Disease|March 11, 2016
Overcoming MITF-conferred drug resistance through dual AURKA/MAPK targeting in human melanoma cellsG Pathria, B Garg, V Borgdorff, et al.The Journal of Pathology|May 1, 1996
Type-1 plasminogen activator inhibitor in human renal cell carcinomaS N Wagner, M J Atkinson, S Thanner, et al.Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|September 1, 1992
Expression of stromelysin 3 in the stromal elements of human basal cell carcinomaS N Wagner, C Ruhri, K Kunth, et al.Laboratory Investigation; a Journal of Technical Methods and Pathology|May 30, 1998
Immune response against human primary malignant melanoma: a distinct cytokine mRNA profile associated with spontaneous regressionS N Wagner, T Schultewolter, C Wagner, et al.Naunyn-Schmiedeberg'S Archives of Pharmacology|April 1, 1996
Inhibition of T cell cAMP formation by cyclosporin A and FK506H M Ockenfels, S N Wagner, P Oeljeklaus, et al.The Journal of Investigative Dermatology|December 20, 2000
Intracutaneous genetic immunization with autologous melanoma-associated antigen Pmel17/gp100 induces T cell-mediated tumor protection in vivoS N Wagner, C Wagner, P Lührs, et al.The American Journal of Pathology|July 1, 1995
Modulation of urokinase and urokinase receptor gene expression in human renal cell carcinomaS N Wagner, M J Atkinson, S Thanner, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1996
Shared epitopes for HLA-A3-restricted melanoma-reactive human CTL include a naturally processed epitope from Pmel-17/gp100J C Skipper, D J Kittlesen, R C Hendrickson, et al.Oncogene|June 4, 2013
A chemical biology approach identifies AMPK as a modulator of melanoma oncogene MITFV Borgdorff, U Rix, G E Winter, et al.Pageof 4